Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 2801 | 271.4 |
09:38 ET | 400 | 271.32 |
09:39 ET | 200 | 270.47 |
09:41 ET | 100 | 270.47 |
09:43 ET | 452 | 271.065 |
09:48 ET | 100 | 271.065 |
09:54 ET | 100 | 271.215 |
09:56 ET | 1500 | 271.12 |
09:57 ET | 750 | 271.35 |
09:59 ET | 1100 | 270.47 |
10:03 ET | 300 | 270.28 |
10:06 ET | 100 | 270.86 |
10:08 ET | 100 | 270.37 |
10:10 ET | 573 | 270.98 |
10:14 ET | 100 | 271.06 |
10:15 ET | 1000 | 270.97 |
10:17 ET | 200 | 270.96 |
10:19 ET | 100 | 271.2 |
10:21 ET | 167 | 271.2 |
10:26 ET | 2727 | 271.295 |
10:28 ET | 200 | 271.12 |
10:30 ET | 300 | 271.045 |
10:37 ET | 200 | 271.11 |
10:42 ET | 100 | 271.105 |
10:44 ET | 100 | 271.08 |
10:46 ET | 946 | 271.07 |
10:57 ET | 900 | 271.09 |
11:00 ET | 900 | 271.49 |
11:02 ET | 100 | 271.49 |
11:04 ET | 400 | 271.435 |
11:08 ET | 100 | 271.66 |
11:09 ET | 700 | 271.74 |
11:11 ET | 200 | 271.835 |
11:13 ET | 200 | 272.165 |
11:15 ET | 380 | 272.035 |
11:18 ET | 100 | 272.2 |
11:20 ET | 3008 | 271.995 |
11:22 ET | 1500 | 272.835 |
11:27 ET | 3064 | 272.41 |
11:29 ET | 1545 | 272.19 |
11:31 ET | 1000 | 272.25 |
11:36 ET | 413 | 272.2226 |
11:47 ET | 100 | 272.71 |
11:49 ET | 100 | 272.58 |
11:56 ET | 100 | 272.69 |
11:58 ET | 100 | 272.69 |
12:00 ET | 1500 | 272.64 |
12:02 ET | 1700 | 272.51 |
12:03 ET | 100 | 272.665 |
12:07 ET | 300 | 272.795 |
12:16 ET | 200 | 272.95 |
12:18 ET | 312 | 272.86 |
12:20 ET | 700 | 273.01 |
12:21 ET | 406 | 272.9644 |
12:23 ET | 500 | 272.935 |
12:34 ET | 300 | 273.08 |
12:36 ET | 100 | 273.095 |
12:38 ET | 200 | 273.565 |
12:43 ET | 2081 | 273.365 |
12:45 ET | 698 | 273.45 |
12:56 ET | 200 | 273.53 |
12:57 ET | 200 | 273.44 |
12:59 ET | 100 | 273.55 |
01:01 ET | 100 | 273.55 |
01:03 ET | 200 | 273.49 |
01:06 ET | 850 | 273.86 |
01:10 ET | 837 | 273.88 |
01:12 ET | 400 | 273.6 |
01:14 ET | 100 | 273.555 |
01:15 ET | 200 | 273.51 |
01:17 ET | 200 | 273.67 |
01:19 ET | 400 | 273.695 |
01:21 ET | 845 | 273.71 |
01:24 ET | 100 | 273.73 |
01:26 ET | 100 | 273.6 |
01:28 ET | 253 | 273.585 |
01:32 ET | 202 | 273.71 |
01:33 ET | 1228 | 273.55 |
01:35 ET | 100 | 273.555 |
01:37 ET | 1566 | 273.28 |
01:39 ET | 200 | 273.39 |
01:42 ET | 400 | 273.51 |
01:50 ET | 100 | 273.87 |
01:53 ET | 100 | 273.69 |
01:57 ET | 700 | 273.395 |
02:00 ET | 729 | 273.49 |
02:06 ET | 100 | 273.61 |
02:08 ET | 600 | 273.61 |
02:13 ET | 100 | 273.67 |
02:15 ET | 700 | 273.785 |
02:18 ET | 600 | 273.84 |
02:22 ET | 200 | 274.16 |
02:24 ET | 307 | 274 |
02:26 ET | 411 | 274.0902 |
02:27 ET | 700 | 274.3525 |
02:31 ET | 100 | 274.24 |
02:33 ET | 1000 | 274.36 |
02:36 ET | 1100 | 274.26 |
02:38 ET | 400 | 274.04 |
02:40 ET | 900 | 273.5 |
02:44 ET | 100 | 273.5 |
02:45 ET | 120 | 273.495 |
02:47 ET | 200 | 273.49 |
02:54 ET | 625 | 273.55 |
02:56 ET | 700 | 273.645 |
02:58 ET | 1006 | 273.95 |
03:02 ET | 1919 | 274.055 |
03:03 ET | 218 | 273.96 |
03:09 ET | 800 | 273.98 |
03:12 ET | 300 | 274.1795 |
03:14 ET | 800 | 274.2 |
03:18 ET | 2005 | 274.28 |
03:21 ET | 600 | 274.32 |
03:23 ET | 509 | 274.225 |
03:25 ET | 500 | 274.32 |
03:27 ET | 400 | 274.42 |
03:30 ET | 804 | 274.41 |
03:32 ET | 2420 | 274.055 |
03:36 ET | 1713 | 273.5 |
03:38 ET | 200 | 273.34 |
03:39 ET | 100 | 273.325 |
03:41 ET | 368 | 273.345 |
03:43 ET | 1895 | 273.6 |
03:45 ET | 400 | 273.77 |
03:50 ET | 1253 | 273.98 |
03:52 ET | 607 | 274.09 |
03:54 ET | 922 | 273.91 |
03:56 ET | 1118 | 274.11 |
03:57 ET | 988 | 274.01 |
03:59 ET | 67036 | 274.26 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 12.2B | 13.0x | +8.22% |
Medpace Holdings Inc | 12.2B | 40.1x | +35.10% |
Biomarin Pharmaceutical Inc | 14.7B | 73.4x | --- |
Exact Sciences Corp | 9.3B | -38.0x | --- |
Qiagen NV | 10.1B | 29.9x | +12.66% |
Neurocrine Biosciences Inc | 14.3B | 39.1x | +62.04% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.2B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.50 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 13.0x |
Price/Sales (TTM) | 4.9 |
Price/Cash Flow (TTM) | 11.0x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.